HHS · Notice · Rel 100 (Federal Register (major agencies))
Government Owned Invention Available for License: Nucleophosmin 1 (NPM1) Mutation-Specific T Cell Receptors for Targeted Treatment of Acute Myeloid Leukemia (AML)
Other · Health / life sciences · general, public-health, nih-funding
Source summary
The NCI seeks research co-development partners or licensees for NPM1 Mutation-Specific T Cell Receptors for Targeted Treatment of AML.
Analyst note
HHS published an official item relevant to other. Use the source link to verify scope before advising clients.
Public reaction (Reddit)
Insufficient public reaction to score sentiment.